111 related articles for article (PubMed ID: 18198227)
1. TFF3-based candidate gene discrimination of benign and malignant thyroid tumors in a region with borderline iodine deficiency.
Krause K; Eszlinger M; Gimm O; Karger S; Engelhardt C; Dralle H; Fuhrer D
J Clin Endocrinol Metab; 2008 Apr; 93(4):1390-3. PubMed ID: 18198227
[TBL] [Abstract][Full Text] [Related]
2. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
[TBL] [Abstract][Full Text] [Related]
3. Genetic markers to discriminate benign and malignant thyroid nodules with undetermined cytology in an area of borderline iodine deficiency.
Tonacchera M; Agretti P; Rago T; De Marco G; Niccolai F; Molinaro A; Scutari M; Candelieri A; Conforti D; Musmanno R; Di Coscio G; Basolo F; Iacconi P; Miccoli P; Pinchera A; Vitti P
J Endocrinol Invest; 2012 Sep; 35(8):754-9. PubMed ID: 21979329
[TBL] [Abstract][Full Text] [Related]
4. [Aspiration biopsy-nucleic acid diagnosis for widely used preparative testing].
Takano T
Rinsho Byori; 2012 Feb; 60(2):132-8. PubMed ID: 22568094
[TBL] [Abstract][Full Text] [Related]
5. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms?
Shibru D; Hwang J; Khanafshar E; Duh QY; Clark OH; Kebebew E
Cancer; 2008 Sep; 113(5):930-5. PubMed ID: 18661512
[TBL] [Abstract][Full Text] [Related]
6. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma.
Takano T; Miyauchi A; Yoshida H; Kuma K; Amino N
Cancer Lett; 2005 Feb; 219(1):91-6. PubMed ID: 15694668
[TBL] [Abstract][Full Text] [Related]
7. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
[TBL] [Abstract][Full Text] [Related]
8. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
Abd-El Raouf SM; Ibrahim TR
Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
[TBL] [Abstract][Full Text] [Related]
10. Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.
Takano T; Yamada H
Endocr J; 2009; 56(1):9-16. PubMed ID: 18506086
[TBL] [Abstract][Full Text] [Related]
11. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.
Weber F; Shen L; Aldred MA; Morrison CD; Frilling A; Saji M; Schuppert F; Broelsch CE; Ringel MD; Eng C
J Clin Endocrinol Metab; 2005 May; 90(5):2512-21. PubMed ID: 15713710
[TBL] [Abstract][Full Text] [Related]
12. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.
Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK
Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
[TBL] [Abstract][Full Text] [Related]
15. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer.
Ringel MD; Anderson J; Souza SL; Burch HB; Tambascia M; Shriver CD; Tuttle RM
Mod Pathol; 2001 Apr; 14(4):289-96. PubMed ID: 11301345
[TBL] [Abstract][Full Text] [Related]
16. Validity of multiplex biomarker model of 6 genes for the differential diagnosis of thyroid nodules.
Ducena K; Abols A; Vilmanis J; Narbuts Z; Tārs J; Andrējeva D; Linē A; Pīrāgs V
Thyroid Res; 2011 Jun; 4(1):11. PubMed ID: 21707985
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of insulin-like growth factor II, cyclooxygenase-2, ets-1 and thyroid-specific thyroglobulin mRNA expression in benign and malignant thyroid tumours.
Fuhrer D; Eszlinger M; Karger S; Krause K; Engelhardt C; Hasenclever D; Dralle H; Paschke R
Eur J Endocrinol; 2005 May; 152(5):785-90. PubMed ID: 15879365
[TBL] [Abstract][Full Text] [Related]
18. [Molecular-based diagnosis of thyroid carcinoma: germ-cell carcinogenesis and aspiration biopsy nucleic acid diagnosis(ABND)].
Takano T; Amino N
Rinsho Byori; 2004 Jan; 52(1):62-6. PubMed ID: 14968562
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
Martins L; Matsuo SE; Ebina KN; Kulcsar MA; Friguglietti CU; Kimura ET
J Clin Endocrinol Metab; 2002 Oct; 87(10):4806-10. PubMed ID: 12364477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
